$MAZE

1 story mentioning MAZEUpdated 84d ago

Every FINWIRES story that references MAZE, newest first.

Maze Therapeutics Insider Sold Shares Worth $393,354, According to a Recent SEC Filing

Harold Bernstein, President, Research and Development, and Chief Medical Officer, on May 14, 2026, sold 15,000 shares in Maze Therapeutics (MAZE) for $393,354.SEC Filing:https://www.sec.gov/Archives/edgar/data/1842295/000205017226000021/xslF345X05/form4-05182026_090546.xml

$MAZE

Track with the FINWIRES app suite

FolioX

Track MAZE in your portfolio

WheelAI

Analyze MAZE options with the wheel strategy

StockInsider

See market sentiment on MAZE